Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05327361 · ClinicalTrials.gov registry record · Phase 2
LiftActiv B3 in Post Inflammatory Hyperpigmentation (PIHP)
A Phase 2 study, sponsored by University of Miami.
- Terminated
- Registry status
- Phase 2
- Development phase
- 13
- Enrollment target
NCT05327361 is a Phase 2 study that was terminated before completion, run by University of Miami. The registered enrollment target is 13 participants.
The verdict
NCT05327361, a Phase 2 study, was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 13 participants
- Enrollment target
Study Summary
The purpose of this research study is to measure the depigmenting effect of a serum product called Liftactiv B3 in patients with mild to moderate facial PIHP (Post Inflammatory Hyper Pigmentation)
Interventions
- OTHER Sunscreen
- DRUG Liftactiv B3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2022-03-22 |
| Est. Completion | 2023-03-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05327361
The ClinicalTrials.gov registry entry for NCT05327361 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sunscreen is the first listed.
NCT05327361 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05327361 about?
NCT05327361 is a clinical study titled "LiftActiv B3 in Post Inflammatory Hyperpigmentation (PIHP)". The purpose of this research study is to measure the depigmenting effect of a serum product called Liftactiv B3 in patients with mild to moderate facial PIHP (Post Inflammatory Hyper Pigmentation)
What is the current status of trial NCT05327361?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 13 participants. The study started on 2022-03-22. Estimated completion is 2023-03-06.
What interventions are being tested in trial NCT05327361?
The interventions under investigation include: Sunscreen (OTHER), Liftactiv B3 (DRUG).
Who is sponsoring clinical trial NCT05327361?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.